Clinical Benefits and Safety of Medical Cannabis Products: A Narrative Review on Natural Extracts

G Mick, P Douek - Pain and Therapy, 2024 - Springer
Interest in medical cannabis and cannabis-based medicinal products (CBMPs) has
increased greatly in recent years. Two cannabinoids are of principal importance; delta-9 …

AGA Clinical Practice Update on Diagnosis and Management of Cannabinoid Hyperemesis Syndrome: Commentary

A Rubio-Tapia, R McCallum, M Camilleri - Gastroenterology, 2024 - Elsevier
Description The purpose of this American Gastroenterological Association (AGA) Institute
Clinical Practice Update (CPU) is to review the available evidence and provide expert …

Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence

CN Andrews, R Rehak, M Woo, I Walker… - Alimentary …, 2022 - Wiley Online Library
Background Cannabinoid hyperemesis syndrome (CHS) is a poorly understood vomiting
disorder associated with chronic cannabis use. Aims To characterise patients experiencing …

Mitofusin-2 mediates cannabidiol-induced neuroprotection against cerebral ischemia in rats

B Xu, M Li, K Chen, X Li, N Cai, J Xu… - Acta Pharmacologica …, 2023 - nature.com
Cannabidiol (CBD) reportedly exerts protective effects against many psychiatric disorders
and neurodegenerative diseases, but the mechanisms are poorly understood. In this study …

Prevalence of cannabis use disorder among individuals using medical cannabis at admission to inpatient treatment for substance use disorders

MNS Gendy, R Taisir, S Sousa, J Costello, B Rush… - Addictive Behaviors, 2023 - Elsevier
Introduction Cannabis is used for medical and recreational purposes and may result in
cannabis use disorder (CUD). This study explored the prevalence of cannabis use disorder …

[HTML][HTML] Intersection between social inequality and emotion regulation on emerging adult cannabis use

SWF Ewing, SL Karalunas, EA Kenyon, M Yang… - Drug and alcohol …, 2022 - Elsevier
Abstract Emerging adulthood (EA; ages 18–25) is characterized by socioemotional and
neurodevelopmental challenges. Cannabis is a widely used substance among EAs, and …

Exploring the role of DARPP-32 in addiction: A review of the current limitations of addiction treatment pathways and the role of DARPP-32 to improve them

MR Greener, SJ Storr - NeuroSci, 2022 - mdpi.com
We are amidst a global addiction crisis, yet stigmas surrounding addiction counterintuitively
prevail. Understanding and appreciating the neurobiology of addiction is essential to …

Exploring medicinal use of low-THC cannabis products-Comparing experienced effects and side-effects between CBD-oil-only users to users of high-THC cannabis …

SL Kvamme, MM Pedersen, KR Thomsen… - … Prevention and Policy, 2024 - Taylor & Francis
Background Low-THC cannabis products have become popular worldwide and are used as
self-treatment for a variety of medical conditions despite limited high-quality evidence on …

A Pilot Study of Physician Assistant Student and Alumni Attitudes, Awareness, and Perceptions of Medical and Recreational Marijuana

K Lawler, A Strauss, A Kaczmarek… - Health Behavior and …, 2024 - ingentaconnect.com
Objectives: In this study, we aimed to explore current physician assistant (PA) student and
alumni attitudes, knowledge, and perceptions towards recreational and medical marijuana …

Cannabis de grado médico para el tratamiento de la dependencia a Δ-9-Tetrahidrocannabinol

F Pavlovsky, R Groisman, AK Hurtado… - … Revista Argentina de …, 2022 - revistavertex.com.ar
Las adicciones son uno de los problemas de salud más importantes a nivel mundial. Dentro
de estos trastornos, el cannabis es una de las sustancias psicoactivas que provoca mayor …